Phase II study finds Nefecon reduces urine albumin in IgA nephropathy patients / News in Context May 26, 2009
Ark Therapeutics enrolls first patient into phase III study of Trinam in end-stage renal disease May 25, 2009
Atrial natriuretic peptide prevents contrast-induced nephropathy in patients with renal failure April 14, 2009
RSS